• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD SAFETYGLIDE¿ INSULIN SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD SAFETYGLIDE¿ INSULIN SYRINGE Back to Search Results
Catalog Number 305934
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 10/31/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Initial reporter phone#: (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd safetyglide¿ insulin syringe package didn't seal well, and the syringe was contaminated.No serious injury or medical intervention was reported.
 
Additional Manufacturer Narrative
Customer returned (14) 1/2cc, 8mm, 30g bd safetyglide insulin syringes in open blister packs from lot # 8019988.Customer states that the package didn¿t seal well.All returned samples were examined and all exhibited an open seal along the side of the blister pack.Samples were forwarded to manufacturing (holdrege) on (b)(6) 2018 for further review.On (b)(6) 2018, holdrege received fourteen (14) 0.5ml, 8mm, 30g bd safetyglide insulin syringes in open blisterpacks from batch# 8019988.All samples were decontaminated per hstr-17 and hqa-68 prior to being evaluated.Upon evaluation by qe ah, similar findings to those documented during initial investigation performed at bd franklin lakes were noted.The returned samples were visually inspected and noted the bottom web to be marked with lane/position identifier "j 5".This type of identification stamp are utilized within the manufacturing process in order to maintain trackability/traceability of the individual devices packaged on the line.The stamp noted on the returned samples represents an outer lane on the packaging equipment.Given the defect noted, this appears to be an alignment issue during the sealing and cutting of the individual blisterpacks.When this occurs, the top and bottom web is not aligned properly so that when the individual blisters are formed from the cut, it impedes the seal(s) in the process.While unusual, this type of event can occur either during a jam or when the equipment is placed into a "jog" functionality to try to realign materials.A review of the device history record was completed for batch# 8019988.All inspections and challenges were performed per the applicable operations qc specifications.There were zero (0) notifications noted that pertained to the complaint.Severity: s_1__; occurrence: a complaint history check was performed and this is the 3rd related complaint for open package/seal (blister pack) on lot # 8019988.Based on the samples / photo(s) received the investigation concluded: confirmed: bd was able to duplicate or confirm the customer¿s indicated failure.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Based on the above, no capa is required at this time.
 
Event or Problem Description
It was reported that bd safetyglide¿ insulin syringe package didn't seal well, and the syringe was contaminated.No serious injury or medical intervention was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SAFETYGLIDE¿ INSULIN SYRINGE
Common Device Name
INSULIN SYRINGE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
MDR Report Key8067863
Report Number1920898-2018-00869
Device Sequence Number19403070
Product Code FMF
UDI-Device Identifier00382903059348
UDI-Public382903059348
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K992734
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other,user facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date02/28/2023
Device Catalogue Number305934
Device Lot Number8019988
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/08/2018
Initial Date Received by Manufacturer 10/31/2018
Supplement Date Received by Manufacturer10/31/2018
Initial Report FDA Received Date11/13/2018
Supplement Report FDA Received Date12/12/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-